LISAvienna: December Newsletter available online

Name: _pk_id Used for : Is used to store an unique ID for each user Duration : 13 Months
Name: &nbsp;_pk_ses, _pk_cvar, _pkhsr Used for :&nbsp;Session cookies that store temporary data Duration :&nbsp;30 minutes
Name: mtm_consent Used for : Stores cookie preferences Duration : 30 years

Take a few minutes to read the news items listed in today’s newsletter. We draw your attention to recent success stories communicated by APEIRON Biologics, Apeptico, Ares Genetics, Biomay, BIOTECh AUSTRIA, Boehringer Ingelheim, enGenes, Eveliqure, F4 Pharma, HOOKIPA Pharma, ingenetix, Lexogen, Marinomed, PhagoMed, P+F, Proxygen, Symptoma, usePAT, Valneva and Vivaldi Biosciences.

In addition, we update you on funding opportunities and digital events.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

LISAvienna: December Newsletter available online

NCP-IP World IP Day Event 2024: Über 150 Teilnehmende aus allen Bereichen des Innovationsschutzes und der Life Sciences

Uni Vienna: Giant Viruses Infect Deadly Parasite

BMAW: Kocher: Österreich auf dem Weg zur höchsten Forschungsquote in der EU